Addpharma Inc.
Clinical trials sponsored by Addpharma Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can two experimental pills work together safely? a trial seeks answers Results expected Sep 2026 (estimated)
- Can a new pill for enlarged prostate match the original? Results expected Oct 2026 (estimated)
- New gastritis drug candidate tested in three formulations to find the best acid controller Results expected Nov 2026 (estimated)
- New knee osteoarthritis drug AD-211 enters phase 2 trial Results expected Mar 2027 (estimated)
-
Prostate drug candidates face off in early safety trial
Disease control Recruiting nowThis early-stage study tests two versions of an experimental drug for benign prostatic hyperplasia (enlarged prostate) in 44 healthy adult men. Each participant receives both drugs at different times to compare safety and how the body processes them. The goal is to see which vers…
Phase 1 • Sponsor: Addpharma Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New stomach ulcer drug put to the test in healthy volunteers
Knowledge-focused Recruiting nowThis early-stage trial compares two versions of a drug called AD-115A and AD-1151, designed to treat gastric ulcers. 46 healthy adults will receive a single dose of each version to see how the drug moves through the body and to check for side effects. The goal is to find out whic…
Phase 1 • Sponsor: Addpharma Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC